| Literature DB >> 19386120 |
Mao L He1, Erasmus K Okine2, Helen Napadajlo1, Priya S Mir1.
Abstract
BACKGROUND: The conjugated linoleic acid (CLA) content of beef can be increased by supplementing appropriate beef cattle diets with vegetable oil or oil seed. Yet the effect of consumption of such beef on adipose tissue characteristics is unclear, thus the study was conducted to compare adipose tissue responses of rats to diets containing beef from steers either not provided or provided the oil supplements to alter CLA composition of the fat in muscle.Entities:
Year: 2009 PMID: 19386120 PMCID: PMC2676290 DOI: 10.1186/1743-7075-6-19
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Dietary ingredients and nutrient composition
| Treatment diets | ||||
| CON | SCLA | CONM | CLAM | |
| L-cystine* cat # 101444 | 30.0 | 30.0 | 30.0 | 30.0 |
| Corn starch* cat# 902956 | 5288.0 | 5277.0 | 5090.0 | 5001.0 |
| Alphacel* cat # 900453 | 500.0 | 500.0 | 500.0 | 500.0 |
| Vitamin mix* cat # 960402 | 100.0 | 100.0 | 100.0 | 100.0 |
| Mineral mix* cat # 960400 | 351.0 | 351.0 | 351.0 | 351.0 |
| Choline bitartrate* cat # 101384 | 25.0 | 25.0 | 25.0 | 25.0 |
| Casein vitamin-free*cat #904520 | 1950.0 | 1950.0 | 1100.0 | 537.0 |
| Sucrose* cat # 902978 | 1000.0 | 1000.0 | 1000.0 | 1000.0 |
| Soybean oil* cat #104687 | 656.0 | 498.0 | 0.0 | 0.0 |
| Synthetic CLA^ | 0.0 | 169.0 | 0.0 | 0.0 |
| Control beef | 0.0 | 0.0 | 1804.0 | 0.0 |
| High CLA beef | 0.0 | 0.0 | 0.0 | 2456.0 |
| DM % | 93.5 | 93.7 | 94.0 | 94.0 |
| Total lipid (%DM) | 7.3 | 7.3 | 5.7 | 7.9 |
| Total protein (%DM) | 19.6 | 20.1 | 19.9 | 21.9 |
| Gross energy (Kcal/g DM) | 4.34 | 4.22 | 4.37 | 4.24 |
*purchased from MP BioMedicals with catalog number (cat #)
^purchased from Bioriginal Food and Sceince Corporation, Saskatoon – Contained 60% Conjugated linoleic acid (CLA) with 53%CLA cis (c)9, trans (t)11 and 44% CLA t10, c12 isomers.
Control beef – beef from steers not provided sunflower seeds (SS) during their production, with composition; 97% dry matter (DM), 52.6% protein and 38.8% lipids in DM.
High CLA Beef-beef from steers fed 14% SS during their production with composition; 95% dry matter (DM), 60.6% protein and 28.5% lipids in DM.
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing and equivalent amount of the soybean oil, CONM – Diet containing control beef, CLAM – diet containing high CLA beef.
Fatty acid (FA) composition of lipids in diets
| Treatment diets | ||||
| Fatty acids* (mg/100 mg) | CON | SCLA | CONM | CLAM |
| C14:0 | 0.06 | 0.09 | 5.26 | 5.47 |
| C14:1 c | 0.00 | 0.00 | 0.84 | 0.69 |
| C16:0 | 5.09 | 5.44 | 24.32 | 23.06 |
| C16:1 c | 0.04 | 0.04 | 3.57 | 2.76 |
| C18:0 | 3.03 | 3.05 | 15.92 | 19.21 |
| C18:1 t11 | 0.01 | 0.01 | 0.19† | 5.55 |
| C18:1 c9 | 11.16 | 11.54 | 37.85 | 30.68 |
| C18:2 c9, c12 | 77.74 | 69.20 | 5.56 | 8.34 |
| C18:3 | 1.62 | 1.42 | 0.10 | 0.11 |
| CLA c9, t11 | 0.03 | 4.64 | 0.29 | 0.49 |
| CLA t10, c12 | 0.00 | 3.20 | 0.02 | 0.04 |
| C20:4 | 0.02 | 0.03 | 0.07 | 0.08 |
| UNS/Total FA | 0.91 | 0.91 | 0.53 | 0.51 |
| UNS/SAT | 10.75 | 10.21 | 1.14 | 1.05 |
| C18:2/C18:3 | 48.04 | 54.43 | 58.61 | 85.96 |
*denoted as Carbon chain length: number of unsaturated bonds in trans (t) or cis (c) position and location
† Calculated from value for control beef in (Shah et al., 2006)
UNS – unsaturated FA, SAT – Saturated FA
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing equivalent amount of the soybean oil, CONM – Diet containing control beef (see table 1), CLAM – diet containing high CLA beef (see table 1).
Effects of synthetic CLA or CLA beef on rat growth performance
| Treatment diets | ||||
| CON | SCLA | CONM | CLAM | |
| Initial BW (g) | 85.5 ± 2.2 | 85.6 ± 2.0 | 86.0 ± 2.3 | 86.3 ± 2.1 |
| BW at 6 wks (g) | 410.6 ± 7.6B | 387.0 ± 7.6A | 413.1 ± 8.0B | 421.6 ± 9.6B |
| Final BW at 9 wks (g) | 486.1 ± 14.7 | 470.2 ± 11.7 | 500.3 ± 13.3 | 509.5 ± 18.4 |
| DWG: 1–42 d (g/d) | 7.7 ± 0.2B | 7.2 ± 0.2A | 7.8 ± 0.2B | 8.0 ± 0.2B |
| DWG: overall (g/d) | 6.4 ± 0.1 | 6.2 ± 0.1 | 6.7 ± 0.2 | 6.8 ± 0.2 |
| FI: 1–42 d (g) | 1053 ± 46A | 932 ± 34A | 1333 ± 81B | 1294 ± 53B |
| FI: overall (g) | 1708 ± 74A | 1566 ± 95A | 2149 ± 159B | 2173 ± 156B |
| Daily FI (g/d) | 27.1 ± 1.1A | 24.9 ± 1.1A | 34.0 ± 2.5B | 33.8 ± 1.9B |
| Protein intake (g) | 333.2 ± 15.0A | 314.8 ± 19.1A | 412.9 ± 26.5B | 458.5 ± 24.1B |
| GE intake (kcal) | 7381 ± 331A | 6608 ± 400A | 9066 ± 583B | 8887 ± 466B |
| GE/BWG: overall (kcal/g) | 18.5 ± 0.85A | 17.1 ± 0.64A | 22.1 ± 1.05B | 21.7 ± 0.94B |
| CLA c9, t11 consumed (g) | 0.04 | 5.31 | 0.34 | 0.81 |
| CLA t10, c12 consumed (g) | - | 3.45 | 0.02 | 0.06 |
A, B: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 14
BW – Body weight, DWG – daily weight gain, FI – feed intake, GE – gross energy,
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing and equivalent amount of soybean oil, CONM – Diet containing control beef (see table 1), CLAM – diet containing high CLA beef (see table 1).
Protein intake – product of diet protein content and FI overall/100.
GE intake – product of diet GE and FI overall.
Consumed CLA c9, t11 or CLA t10, c12 – calculated from means, CLA c9, t11 or CLA t10, c12 percent in diet × diet fat content × FI overall/10000; respectively.
Carcass components, cellularity of fat pads and concentrations of blood glucose, cholesterol and triglycerides in the rats
| Treatment diets | ||||
| CON | SCLA | CONM | CLAM | |
| Carcass weight (g) | 395.33 ± 11 | 374.73 ± 10 | 392.90 ± 10 | 402.86 ± 13 |
| Heart (g) | 1.50 ± 0.03 | 1.51 ± 0.04 | 1.44 ± 0.04 | 1.53 ± 0.04 |
| Heart/BW (%) | 0.31 ± 0.01AB | 0.32 ± 0.01B | 0.29 ± 0.01A | 0.30 ± 0.01AB |
| Liver (g) | 13.74 ± 0.31 | 13.42 ± 0.29 | 13.18 ± 0.53 | 14.06 ± 0.53 |
| Liver/BW (%) | 2.85 ± 0.08B | 2.86 ± 0.06B | 2.64 ± 0.09A | 2.77 ± 0.07AB |
| Kidney (g) | 3.13 ± 0.08 | 3.22 ± 0.08 | 3.11 ± 0.06 | 3.17 ± 0.06 |
| Kidney/BW (%) | 0.65 ± 0.02AB | 0.69 ± 0.02B | 0.62 ± 0.01A | 0.63 ± 0.02A |
| Soleus (g) | 0.33 ± 0.10 | 0.20 ± 0.01 | 0.22 ± 0.01 | 0.21 ± 0.01 |
| Soleus/BW (%) | 0.06 ± 0.016 | 0.04 ± 0.002 | 0.04 ± 0.001 | 0.04 ± 0.002 |
| Gastrocnemius (g) | 2.73 ± 0.12 | 2.57 ± 0.09 | 2.72 ± 0.06 | 2.84 ± 0.06 |
| Gastrocemius/BW (%) | 0.57 ± 0.03 | 0.55 ± 0.02 | 0.55 ± 0.02 | 0.56 ± 0.02 |
| Weight (g) | 12.85 ± 1.26B | 8.68 ± 1.07A | 16.86 ± 1.58C | 16.98 ± 1.91C |
| RP/BW (%) | 2.61 ± 0.22B | 1.80 ± 0.19A | 3.32 ± 0.26C | 3.22 ± 0.25C |
| n × 107 cells/g | 26.90 ± 7.16 | 9.38 ± 2.10 | 22.28 ± 5.95 | 23.39 ± 4.44 |
| Weight (g) | 10.12 ± 0.98AB | 7.62 ± 0.48A | 11.69 ± 0.86B C | 12.80 ± 1.54C |
| IG/BW (%) | 2.06 ± 0.18B | 1.60 ± 0.07A | 2.31 ± 0.13C | 2.42 ± 0.21C |
| n × 107 cells/g | 20.15 ± 4.18AB | 26.01 ± 5.94B | 28.88 ± 5.56B | 7.26 ± 1.28A |
| Glucose (g/L) | 1.27 ± 0.04 bB | 1.17 ± 0.05A | 1.39 ± 0.05B | 1.37 ± 0.06B |
| Cholesterol (g/L) | 0.60 ± 0.03 | 0.59 ± 0.05 | 0.59 ± 0.04 | 0.63 ± 0.07 |
| Triglycerides (g/L) | 0.73 ± 0.08 | 0.79 ± 0.06 | 0.77 ± 0.06 | 1.04 ± 0.13 |
A-C: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 14
BW – body weight
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing an equivalent amount of soybean oil, CONM – Diet containing control beef (see table 1), CLAM – diet containing high CLA beef (see table 1).
Figure 1Comparison of the total number of adipocytes in fat tissues from rats fed with various diets. A, B: Means (± standard error) denoted by a different letter differ (p < 0.05); n = 14. CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing and equivalent amount of soybean oil, CONM – Diet containing control beef (from steers not provided sunflower seeds (SS) during their production, with composition; 97% dry matter (DM), 52.6% protein and 38.8% lipids in DM), CLAM – diet containing high CLA beef (from steers fed 14% SS during their production with composition; 95% dry matter (DM), 60.6% protein and 28.5% lipids in DM).
Effects of synthetic CLA or high CLA beef on fatty acid composition of retroperitoneal fat of the rats
| Treatment diets | ||||
| CON | SCLA | CONM | CLAM | |
| Lipid (% tissue) | 81.33 ± 2.32 | 80.15 ± 3.80 | 84.54 ± 2.43 | 87.68 ± 5.24 |
| Fatty acid concentration (mg/100 mg of detected fatty acids) | ||||
| C14:0* | 1.13 ± 0.096 | 1.06 ± 0.065 | 1.67 ± 0.089 | 1.99 ± 0.103 |
| C14:1 c | 0.01 ± 0.004A | 0.01 ± 0.005A | 0.46 ± 0.016B | 0.44 ± 0.015B |
| C16:0 | 22.92 ± 0.83 | 25.37 ± 0.51 | 23.88 ± 0.48 | 25.28 ± 0.71 |
| C16:1 c | 4.79 ± 0.22B | 2.88 ± 0.14A | 6.78 ± 0.28C | 6.31 ± 0.32C |
| C18:0 | 3.74 ± 0.13A | 3.47 ± 0.30A | 4.63 ± 0.33B | 6.00 ± 0.26C |
| C18:1 t11 | 0.00 ± 0.73 | 0.65 ± 0.63 | 1.01 ± 0.63 | 2.14 ± 0.83 |
| C18:1 c9 | 28.86 ± 0.66A | 25.10 ± 0.77A | 52.48 ± 0.91B | 48.31 ± 1.54B |
| C18:2 c9, c12 | 30.49 ± 2.46C | 26.60 ± 1.40B | 2.58 ± 0.36A | 3.50 ± 0.39A |
| C18:3 | 3.0 ± 0.07C | 2.33 ± 0.03B | 0.17 ± 0.01A | 0.14 ± 0.01A |
| CLA c9, t11 | 0.01 ± 0.002A | 4.50 ± 0.408C | 0.38 ± 0.011B | 0.60 ± 0.041B |
| CLA t10, c12 | 0.10 ± 0.003A | 3.16 ± 0.081B | 0.23 ± 0.006A | 0.19 ± 0.007A |
| C20:4 | 0.41 ± 0.17 | 0.21 ± 0.014 | 0.28 ± 0.003 | 0.21 ± 0.010 |
| C22:5 | 0.18 ± 0.007 | 0.39 ± 0.004 | 0.49 ± 0.000 | 0.42 ± 0.000 |
| C22:6 | 0.78 ± 0.011 | 0.60 ± 0.007 | 0.81 ± 0.000 | 0.86 ± 0.000 |
| UNS/Total FA | 0.72 ± 0.02B | 0.69 ± 0.01AB | 0.68 ± 0.01AB | 0.65 ± 0.01A |
| UNS/SAT | 2.60 ± 0.19B | 2.27 ± 0.16AB | 2.18 ± 0.06AB | 1.91 ± 0.09A |
| C18:2/C18:3 | 9.99 ± 0.58A | 14.43 ± 0.27AB | 20.36 ± 3.15BC | 25.66 ± 2.42C |
A-C: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 7
*denoted as Carbon chain length: number of unsaturated bonds in trans (t) or cis (c) position and location
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing an equivalent amount of soybean oil, CONM – Diet containing control beef (see table 1), CLAM – diet containing high CLA beef (see table 1).
Effects of synthetic CLA or high CLA beef on fatty acid composition of inguinal fat of the rats
| Treatment diets | ||||
| CON | SCLA | CONM | CLAM | |
| Lipid (% tissue) | 85.09 ± 2.2 | 76.94 ± 1.68 | 81.30 ± 2.50 | 84.22 ± 4.42 |
| Fatty acid concentration (mg/100 mg of detected fatty acids) | ||||
| C14:0* | 0.58 ± 0.094 | 1.48 ± 0.441 | 2.03 ± 0.097 | 2.48 ± 0.39 |
| C14:1 c | 0.00 ± 0.005A | 0.00 ± 0.005A | 0.55 ± 0.013B | 0.50 ± 0.42B |
| C16:0 | 22.97 ± 1.59 | 25.45 ± 1.08 | 23.50 ± 0.29 | 24.30 ± 2.25 |
| C16:1 c | 5.14 ± 0.23AB | 3.53 ± 0.16A | 8.05 ± 0.29C | 7.56 ± 0.66BC |
| C18:0 | 3.51 ± 0.29A | 3.02 ± 0.07A | 4.15 ± 0.40AB | 5.04 ± 0.27B |
| C18:1 t11 | 0.42 ± 0.91 | 0.64 ± 1.72 | 0.71 ± 1.17 | 3.67 ± 1.21 |
| C18:1 c9 | 27.56 ± 2.32A | 24.53 ± 2.01A | 52.23 ± 0.73C | 46.44 ± 4.10B |
| C18:2 c9, c12 | 30.77 ± 2.28B | 26.63 ± 1.77B | 2.87 ± 0.19A | 3.50 ± 0.99A |
| C18:3 | 3.25 ± 0.06C | 2.58 ± 0.05B | 0.18 ± 0.01A | 0.29 ± 0.02A |
| CLA c9, t11 | 0.00 ± 0.04A | 4.54 ± 0.08C | 0.42 ± 0.01B | 0.79 ± 0.09B |
| CLA t10, c12 | 0.19 ± 0.002A | 2.92 ± 0.031B | 0.08 ± 0.002A | 0.32 ± 0.008A |
| C20:4 | 0.53 ± 0.026B | 0.27 ± 0.024A | 0.09 ± 0.015A | 0.05 ± 0.012A |
| C22:5 | 0.42 ± 0.005 | 0.25 ± 0.006 | 0.16 ± 0.003 | 0.50 ± 0.001 |
| C22:6 | 0.63 ± 0.015 | 0.49 ± 0.009 | 0.69 ± 0.009 | 0.80 ± 0.003 |
| UNS/Total FA | 0.72 ± 0.01B | 0.69 ± 0.01AB | 0.69 ± 0.00AB | 0.67 ± 0.01A |
| UNS/SAT | 2.61 ± 0.1B | 2.24 ± 0.1AB | 2.22 ± 0.04AB | 2.05 ± 0.1A |
| C18:2/C18:3 | 9.18 ± 0.32A | 12.94 ± 0.21AB | 15.98 ± 2.46B | 16.66 ± 4.15B |
A-C: Means (± standard error) in a row denoted by a different letter differ (p < 0.05); n = 7
*denoted as Carbon chain length: number of unsaturated bonds in trans (t) or cis (c) position and location
CON – Control diet, SCLA – diet with 1.69% synthetic CLA replacing an equivalent amount of soybean oil, CONM – Diet containing control beef (see table 1), CLAM – diet containing high CLA beef (see table 1).